Search
for
Sort by
Research 721–750 of 1000+
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Research Progress in Chronic Autoimmune Urticaria
- RNA sequencing reveals lncRNA-mediated non-mendelian inheritance of feather growth change in chickens
- Gut microbiome, metabolome and alopecia areata
- ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease
- Vitiligo
- Anthocyanin as Colorectal Anticancer: A Brief Review
- What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered?
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Janus kinase inhibitors for alopecia areata: A narrative review
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- Deucravacitinib in dermatology: current indication and existing off-label data
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases
- Baricitinib (Olumiant)
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Complete Reversal of Alopecia Universalis Using Tofacitinib in a Patient with Rheumatoid Arthritis: A Case Report
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
- Modern dermatology brings treatment even for alopecia areata
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib